참고문헌
- Aging-Daewoo science library-. Kim SH;Kim WY
- Future estimation of population Board of Statistics.
- Dementia and Aging -Ethics, Values, and Policy Choices-. Binstock RH;Post SG;Whitehouse PJ
- Alzheimer's-A caregiver's guide and sourcebook-. Gruetzner H
- JAMA v.271 Influence of education and occupation on the incidence of Alzheimer's disease Stern Y;Gurland B;Tatamichi TK;Tang MX;Wilder D;Mayeux R
- Am J Epidemiol v.143 Variables associated with cognitive function in elderly California seventhday adventists Raser GE;Singh PN;Bennett H
- Hypertension v.9 Clinical significance of cognitive performance by hypertensive patients Elias MF;Robbins MA;Schultz NR;Streeten DH;Elias PK
- Family nutritional -Daewoo science library-. Kim SH;Yoo CH;Kim SH;Lee SS;Kang MH;Chang NS
- Am J Clin Nutr v.65 Nutritional status and cognitive functioning in a normally aging smaple : A6-y reassessment Rue AL;Koehler KM;Wayne SJ;Chiulli SJ;Haaland KY;Garry PJ
- Nutrition Reviews v.37 no.5 Dietary influences on the Synthesis of Neurotransmitters in the brain Growdon JH;Wurtman RJ
- Kor J Diet Cult v.7 no.2 A study on the realtion between dietary intake and cognitive function in the elderly Park SO;Han SS;Ko YS;Kim YJ;Lee HS;Kang NE;Lee JH;Kim WK;Kim SH
- Am J Clin Nutr v.55 Nutritional factors in physical and cognitive function of elderly people Rosenberg IH;Miller JW
- Nueroscience Letter v.174 no.1 Concentrations of gamma-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia Tohgi H;Abe T;Nakanishi M;Hamato F;Sasaki K;Takahashi S
- Age Aging v.21 no.2 Plasma concentrations of vitamin A and E and carotenoids in Alzheimer's disease Zaman Z;Roche S;Fielden P;Frost PG;Niriella DC;Cayley ACD
- Gerontology v.35 no.5-6 Lipid peroxidation and free radical scavengers in Alzheimer's disease Jeandel C;Nicolas MB;Dubois F;Nabet-Belleville F;Penin F;Cuny G
- N Engl J Med v.336 no.17 A controlled trial of selegilline, alpha-tocopherol, of both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study Sano M;Ernesto C;Thomas RG;Klauber MR;Schafer K;Grudman M;Woodbury P;Growdon J;Cotman CW;Pfeiffer E;Schneider LS;Thal LJ
- Medical Hypotheses v.48 no.5 The possible role of peroxynitrite in Alzheimer's disease : A simple hypothsis that could be tested more thoroughly Van Dyke K
- JAMA v.249 Association between nutritional status and cognitive functioning in a healthy population Goodwin JS;Good JM;Gerry PJ
- Arch Gerontol Geriatr v.21 no.1 Ascorbic acid in cerebrospinal fluid -A possible protection against free radicals in the brain Barabas J;Nagy E;Degrell I
- Europ J Clin Nutr v.42 no.7 Dietary intakes and nutritional status of old people with dementia living at home in Oslo Nes M;Sem SW;Rousseau B;Bjorneboe GEA;Engedal K;Trygg K;Pedersen JI
- Acta Neurol Scand v.92 no.2 Posatirelin for the treatment of late-onset Alzheimer's disease : A double blind multicentre study vs citicoline and ascorbic acid Parnetti L;Ambrosoli L;Abate G;Azzini C;Balestreri R;Barotorelli L;Bordin A;Crepaldi G;Cristianini G;Cucinotta D;Cuzzupoli M;De Candia O;Fabris F;Maggioni M;Scarpa R;Villardita C;Girardello R;Poli A;Senin U
- Neurobiology of Learning & Memory v.64 no.2 The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice de Angelis L;Furlan C
- The annual report of KFDA v.1 Biochemical study on Alzheimer's disease(I) Kang SY;Kim SH;Kim TG;Jung KK;Ko HS;Huh YB;Lee SD;Lee YK
- Psychopharmacology v.83 Cholinergic learning deficits in the marmoset produced by scopolamine and 1CV hemicholinium Ridley BM;Barratt NG;Baker HF
- Natural and Synthetic Neurotoxins Harvey AL
- Biochemical Pharmacology v.7 A new and rapid colorimetric determination of acetylcholinesterase activity Ellman GL;Courtney D;Andres V Jr;Featherstone RM
- Kor J Nutr v.29 no.1 Effect of DHA and environmental enrichment on brain fatty acid composition and acetylcholinesterase activity Kim MJ;Kim SH
- J Chrom v.309 Rapid automated analysis of biogenic amines and their metabolites using reversed-phase high performance liquid chromatography with electrochemical detection Saller CF;Salama AI
- Brain Res v.418 Dopamine mediates the light-evoked suppression of serotonin N-acetyltransferase activity in retina Iuvone PM;Boatright JH;Bloom MM
- SAS and statistics consulting Cho IH
- Europ J Pharm v.309 no.2 Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septum-lesioned and aged rats Riekkinen P Jr;Schmidt B;Stefanski R;Kuitunen J;Riekkinen M
- J Ethnopharmacology v.50 no.2 Effect of Hachimi-jio-gan on scopolamine-induced memory impairment and on acetylcholine content in rat brain Hirokawa S;Nose M;Ishige A;Amagaya S;Oyama T;Ogihara Y
- Brain Res v.171 Neurotransmitter-related enzymes in senile dementia of the Alzheimer type Davis P
- Kor J Nutr v.28 no.8 Influence of dietary linolenic acid/linoleic acid ratio on brain lipid composition and acetylcholinesterase activity in different aged rat Yoon GA
- Lancet v.349 no.9068 Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease Iyo M;Namba H;Fukushi K;Shinotoh H;Nagatsuka S;Suhara T;Sudo Y;Suzuki K;Irie T
- Medical Hypothesis v.47 no.5 The significance of the activity of CSF cholinesterases in dementias Shen ZX
- Annals of Clinical & Laboratory Science v.26 no.4 Laboratory examinations correlated with severity of dementia Oishi M;Mochizuki Y;Yoshihashi H;Takasu T;Nakano E
- Am J Chinese Med v.24 no.3-4 Regulatory effect of danggui-shaoyaosan on central cholinergic nervous system dysfunction in mice Itoh T;Michijiri S;Murai S;Saito H;Nakamura K;Itsukaichi O;Fujiwara H;Ookubo N;Saito H
- Br J Clin Practice v.48 no.6 Therapy options in Alzheimer's disease Gottfries CG
- JAMA v.271 no.13 A 30-week randomized controlled trial of high-dose Tacrine in patients with Alzheimer's disease Knapp MJ;Knopman DS;Solomon PR;Pendlebury WW;Davis CS;Gracon SI
- N Engl J Med v.327 no.18 A double-blind, placebo-controlled multicenter study of Tacrine for Alzheimer's disease Davis KL;Thal LJ;Gamzu ER;Davis CS;Woolson RF;Gracon SI;Drachman DA;Schneider LS;Whitehouse PJ;Hoover TM;Morris JC;Kawas CH;Knopman DS;Earl NL;Kumar V;Doody RS
- JAMA v.268 no.18 A controlled trial of Tacrine in Alzheimer's disease Farlow M;Gracon SI;Hershey LA;Lewis KW;Sadowsky CH;Dolan-Ureno J
- Journal of Pharmacology & Experimental Therapeutics v.277 no.2 Pharmacological evaluation of novel Alzheimer's disease therapeutics : Acetylcholinesterase inhibitors related to galanthamine Bores GM;Huger FP;Petko W;Mutlib AE;Camacho F;Rush DK;Selk DE;Wolf V;Kosley RW JR;Davis L;Vargas HM
- Neuroscience v.76 no.1 Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus Chapman CA;Yeomans JS;Blaha CD;Blackburn JR
- Ann Nucl Med v.8 no.4 Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET Itoh M Meguro K;Fujiwara T;Hatazawa J;Iwata R;Ishiwata K;Takahashi T;Ido T;Sasaki H
- Nihon Shinkei Seishin Yakurigaku Zasshi v.16 no.3 Experimental techniques for developing new drugs acting on dementia -Alzheimer's disease animal model induced by beta-amyloid protein Nitta A;Nabeshima T
- Br Med J v.288 no.31 Neurochemical characteristics of early and late onset types of Alzheimer's disease Rossor MN;Iversen Ll;Reynolds GP;Mountjoy CQ;Roth M
- Kor J Psychopharmacol v.3 no.1 Biochemistry and molecular biology of dementia Suh Y
- Biological Psychiatry v.38 no.3 Plasma 3-methoxy-4-hydroxyphenylglycol(MHPG) and clinical symptoms in Alzheimer's disease Lawlor BA;Bierer LM;Ryan TM;Schmeidler J;Knott PJ;Williams LL;Mohs RC;Davis KL
- J Neurol Sci v.136 no.1-2 Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases Ahlskog JE;Uitti RJ;Tyce GM;O'Brien JF;Petersen RC;Kokmen E
- Biological Psychiatry v.34 no.7 Autonomic dysfunction in patients with dementia of the Alzheimer type Vitiello B;Veith RC;Molchan Se;Martinez RA;Lawlor BA;Radcliffe J;Hill JL;Sunderland T
- Pharmacology Biochemistry & Behavior v.57 no.1-2 Noradrenergic DSP-4 lesions aggravate impairment of working memory produced by hippocampal muscarinic blockade in rats Ohno M;Yoshimatsu A;Kobayashi M;Watanabe S
- Behavioural Brain Research v.78 no.2 The role of brain noradrenaline in cortical activation and behavior : A study of lesions of the locus coeruleus, medial thalamus and hippocampusneocortex and of muscarinic blockade in the rat Vanderwolf CH;Baker GB
- Fundamental aspects in nutrition and health The vitamins Gerald F;Combs JR
- Nutritional, biochemical, and clinical aspects Handbook of vitamins Lawrence JM